PDS Biotechnology Corp — Director's Dealing 2019

Mar 26, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PDS Biotechnology Corp (PDSB)
CIK: 0001472091
Period of Report: 2019-03-15

Reporting Person: Freitag Gregory Gene (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1871	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$6.87	2024-12-15	Common Stock (17649)		Direct
Stock Option (Right to Buy)	$9.04	2029-03-14	Common Stock (11218)		Direct

Footnotes

F1: Stock Option fully vested in accordance with its terms.

F2: Stock Option fully vested on date of grant.